Literature DB >> 9637579

Cardiac manifestations of HIV/AIDS: a review of disease spectrum and clinical management.

N A Yunis1, V E Stone.   

Abstract

HIV and AIDS involve multiple organ systems. Lungs, brain, skin, gastrointestinal tract, kidneys, and heart are the major organs targeted by the direct effects of HIV infection and the secondary opportunistic complications of AIDS. Although most other organ system involvement has been extensively described in numerous studies and reviews, cardiac abnormalities related to HIV infection have remained less well characterized, partially because their pathogenesis was less clear and their clinical significance was uncertain. Most studies that have described cardiac complications in AIDS patients were postmortem, although some clinical series have been reported. It is now clear that cardiac involvement in AIDS patients is relatively common. Although most such conditions are clinically quiescent, some may have devastating and fatal outcomes. Pericardial effusion and myocarditis are among the most commonly reported abnormalities. Cardiomyopathy, endocarditis, and coronary vasculopathy have also been reported. In this review, we discuss the most common cardiac abnormalities in HIV-infected patients, as well as their clinical significance, clinical presentation, and management.

Entities:  

Mesh:

Year:  1998        PMID: 9637579     DOI: 10.1097/00042560-199806010-00006

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  14 in total

Review 1.  Cardiovascular manifestations of HIV infection.

Authors:  G Barbaro
Journal:  J R Soc Med       Date:  2001-08       Impact factor: 5.344

2.  Secondary and Infiltrative Cardiomyopathies.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-10

Review 3.  HIV and cardiovascular medicine.

Authors:  B D Prendergast
Journal:  Heart       Date:  2003-07       Impact factor: 5.994

4.  Myocardial and Pericardial Disease in HIV.

Authors:  William G. Harmon; Gul H. Dadlani; Stacy D. Fisher; Steven E. Lipshultz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-12

5.  Red blood cell deformability in patients with human immunodeficiency virus infection.

Authors:  G A Athanassiou; A G Moutzouri; C A Gogos; A T Skoutelis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-05       Impact factor: 3.267

Review 6.  Mitochondrial toxicity and HIV therapy.

Authors:  A J White
Journal:  Sex Transm Infect       Date:  2001-06       Impact factor: 3.519

7.  Selective expression of human immunodeficiency virus Nef in specific immune cell populations of transgenic mice is associated with distinct AIDS-like phenotypes.

Authors:  Zaher Hanna; Elena Priceputu; Pavel Chrobak; Chunyan Hu; Véronique Dugas; Mathieu Goupil; Miriam Marquis; Louis de Repentigny; Paul Jolicoeur
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

8.  Antiretroviral Drug Levels and Interactions Affect Lipid, Lipoprotein, and Glucose Metabolism in HIV-1 Seronegative Subjects: A Pharmacokinetic-Pharmacodynamic Analysis.

Authors:  Susan L Rosenkranz; Kevin E Yarasheski; Michael F Para; Richard C Reichman; Gene D Morse
Journal:  Metab Syndr Relat Disord       Date:  2007-06       Impact factor: 1.894

9.  Cardiovascular Complications in Patients with HIV Infection.

Authors:  Karolina M. Zareba; Steven E. Lipshultz
Journal:  Curr Infect Dis Rep       Date:  2003-12       Impact factor: 3.725

10.  HIV Tat induces expression of ICAM-1 in HUVECs: implications for miR-221/-222 in HIV-associated cardiomyopathy.

Authors:  Ming Duan; Honghong Yao; Guoku Hu; XianMing Chen; Amie K Lund; Shilpa Buch
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.